Amphetamine Increases Errors During Episodic Memory Retrieval
Overview
Affiliations
Moderate doses of stimulant drugs are known to enhance memory encoding and consolidation, but their effects on memory retrieval have not been explored in depth. In laboratory animals, stimulants seem to improve retrieval of emotional memories, but comparable studies have not been carried out in humans. In the present study, we examined the effects of dextroamphetamine (AMP) on retrieval of emotional and unemotional stimuli in healthy young adults, using doses that enhanced memory formation when administered before encoding in our previous study. During 3 sessions, healthy volunteers (n = 31) received 2 doses of AMP (10 and 20 mg) and placebo in counterbalanced order under double-blind conditions. During each session, they first viewed emotional and unemotional pictures and words in a drug-free state, and then 2 days later their memory was tested, 1 hour after AMP or placebo administration. Dextroamphetamine did not affect the number of emotional or unemotional stimuli remembered, but both doses increased recall intrusions and false recognition. Dextroamphetamine (20 mg) also increased the number of positively rated picture descriptions and words generated during free recall. These data provide the first evidence that therapeutic range doses of stimulant drugs can increase memory retrieval errors. The ability of AMP to positively bias recollection of prior events could contribute to its potential for abuse.
Doss M, de Wit H, Gallo D Neurosci Biobehav Rev. 2023; 150:105188.
PMID: 37085021 PMC: 10247427. DOI: 10.1016/j.neubiorev.2023.105188.
Minassian A, Kelsoe J, Miranda A, Young J, Perry W Psychiatry Res. 2022; 316:114776.
PMID: 35964417 PMC: 9885942. DOI: 10.1016/j.psychres.2022.114776.
Amphetamine Modulation of Long-Term Object Recognition Memory in Rats: Influence of Stress.
Colucci P, Santori A, Romanelli L, Zwergel C, Mai A, Scaccianoce S Front Pharmacol. 2021; 12:644521.
PMID: 33716754 PMC: 7943736. DOI: 10.3389/fphar.2021.644521.
Clos M, Bunzeck N, Sommer T Neuropsychopharmacology. 2018; 44(3):555-563.
PMID: 30356095 PMC: 6333779. DOI: 10.1038/s41386-018-0246-y.
Doss M, Weafer J, Ruiz N, Gallo D, de Wit H Cogn Neurosci. 2018; 9(3-4):89-99.
PMID: 30044718 PMC: 6309693. DOI: 10.1080/17588928.2018.1504764.